Study to Assess the Bioequivalence of Ibrutinib 140 Milligram (mg) Tablet to 140 mg IMBRUVICA Capsule
Clinical trial NCT02877225 · COMPLETED
Trial details
- NCT number
- NCT02877225
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-29
- Primary completion
- 2016-11-11
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.